Procter and Gamble (US) to market periodontal test:
This article was originally published in Clinica
Procter & Gamble (US) has gained an option to market Xytronyx' periodontal tissue monitor worldwide, except Japan. Already approved in Canada, China and Europe, the periodontitis test provides results in a few minutes following insertion of a strip of absorbent paper between the tooth and the gum. Xytronyx, based in San Diego, expects to complete US clinical trials by April next year after which it will apply for FDA clearance.